Doesn't it make you wonder why if the story is so good nobody gives a damn? Maybe its just sales talk. All puff.
Roche deal was peanuts. So will the others be. Even though they are talking about being cash fow positive soon, up front licencing cash does not get PE rated because its not product in market.
- Forums
- ASX - By Stock
- finance news network interview with paul watt
PYC
pyc therapeutics limited
Add to My Watchlist
0.37%
!
$1.36

Doesn't it make you wonder why if the story is so good nobody...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.36 |
Change
0.005(0.37%) |
Mkt cap ! $793.2M |
Open | High | Low | Value | Volume |
$1.40 | $1.40 | $1.36 | $211.9K | 152.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4103 | $1.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.39 | 2028 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4103 | 1.360 |
2 | 2584 | 1.350 |
1 | 6000 | 1.310 |
2 | 1386 | 1.300 |
1 | 4109 | 1.230 |
Price($) | Vol. | No. |
---|---|---|
1.385 | 2028 | 1 |
1.390 | 15000 | 1 |
1.395 | 13000 | 1 |
1.400 | 2000 | 1 |
1.410 | 7800 | 1 |
Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |